Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neuroblastoma Biology Studies

NCT00904241 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00904241
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00904241 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neuroblastoma Biology Studies
Lead sponsor
Children's Oncology Group
Phase
Observational
Overall status
Completed
Start date
November 6, 2000
Completion date
March 31, 2026
Enrollment
10,000 (estimated)
Sites
259

Conditions

As the registry lists them; a condition with its own page is linked.

ganglioneuroblastoma, localized resectable neuroblastoma, localized unresectable neuroblastoma, regional neuroblastoma, stage 4 neuroblastoma, stage 4s neuroblastoma